PSA On Vaping and Safety
At Ilera Healthcare, we are committed to improving the lives of the patients we serve by continuing to provide safe, clean, and responsible medicine to the patients of Pennsylvania.
In light of the recent news stories regarding vaping and safety, ILERA Healthcare would like to clearly state that our vaping products are free from additives, such as vitamin acetates and vitamin E, nor do we use cutting agents such as polyethylene glycol (PEG), propylene glycol (PG) and vegetable glycerin (VG) which are used by some vape manufacturers.
ILERA Healthcare produces and sells clean oil products that pass both in-house and state-mandated testing protocols for contaminants, heavy metals and pesticides. This product testing takes place during three separate steps in the production process prior to getting into the hands of dispensaries and patients.
We are proud to be a part of the Pennsylvania medical marijuana program, a program that was developed with patient safety as a paramount concern. As part of that program:
- Medical marijuana products sold on shelves in PA must be approved by the Pennsylvania Department of Health after considerable testing.
- Vitamin E acetate is not allowed in vaporization products in Pennsylvania.
- Only oils derived from state permitted growers and processors can be sold in Pennsylvania.
We invite you to reach out to us with any questions or concerns by emailing, email@example.com.
Woman are getting certified for pain due to endometriosis, pelvic floor pain, vulvodynia and interstitial cystitis. Although vaping, tinctures and capsules can provide some relief, utilizing vaginal suppositories can provide even more relief as they are able to target the issue right at the source.
23 chronic insomnia patients treated with ZLT-101, Zelira’s proprietary and patented medicinal cannabis formulation, demonstrated statistically significant improvement in Insomnia Severity Index scores compared to placebo.
This research evaluates thousands of subjects who are current or past participants in the Pennsylvania Medical Marijuana Program who were asked to answer a variety of questions based on their first-hand experience.